Sirana enters into collaborative research agreement with Pfizer
Companies will combine to investigate a novel treatment for a rare bone disease - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Michael Kring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies will combine to investigate a novel treatment for a rare bone disease - News - PharmaTimes
Sirana Pharma and Pfizer are to investigate a novel treatment concept for osteogenesis imperfecta, or brittle bone disease.